10-K

Company

KIORA PHARMACEUTICALS INC

Filed

April 15, 2022

Period of Report

December 31, 2021

Accession Number

0001410578-22-000925

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →